Design and Study of Piracetam-like Nootropics, Controversial Members of the Problematic Class of Cognition-Enhancing Drugs

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|8|2|125-138

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.8, Iss.2, 2002-01, pp. : 125-138

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

2-Pyrrolidinone moiety is not critical for the cognition-enhancing activity of piracetam-like drugs

By Scapecchi S.   Martelli C.   Ghelardini C.   Guandalini L.   Martini E.   Gualtieri F.  

Il Farmaco, Vol. 58, Iss. 9, 2003-09 ,pp. : 715-722

Elsevier

Access to resources Recommend Favorite

Piracetam and Piracetam-Like Drugs: From Basic Science to Novel Clinical Applications to CNS Disorders

By Malykh Andrei G.   Sadaie M. Reza  

Drugs, Vol. 70, Iss. 3, 2010-02 ,pp. : 287-312

Adis International

Access to resources Recommend Favorite

Memory Assessment in Studies of Cognition-Enhancing Drugs for Alzheimer's Disease

By Simard M.   van Reekum R.  

Drugs & Aging, Vol. 14, Iss. 3, 1999-03 ,pp. : 197-230

Adis International

Access to resources Recommend Favorite

Cognition-Enhancing Drugs in Mild Cognitive Impairment (MCI) and Alzheimer's Disease (AD): An Update [1]

By  

Medicinal Chemistry Reviews - Online, Vol. 2, Iss. 6, 2005-12 ,pp. : 471-487

Bentham Science Publishers

Access to resources Recommend Favorite

The Psychopharmacology of European Herbs with Cognition-Enhancing Properties

By  

Current Pharmaceutical Design, Vol. 12, Iss. 35, 2006-12 ,pp. : 4613-4623

Bentham Science Publishers

Access to resources Recommend Favorite